logo

EXOZ

eXoZymes·NASDAQ
--
--(--)
--
--(--)
3.71 / 10
Netural

eXoZymes' fundamentals are rated neutral (3.7/10). Key positives include a healthy profit-to-market value ratio (0.474) and net-income-to-revenue ratio (-0.152), but challenges remain in asset-to-market value (-0.507) and revenue-to-market value (-0.264). Efficiency ratios such as inventory turnover (47.88) and fixed-asset turnover (7993.84) are strong, yet current-asset turnover (1.78) is only moderate. Gross margin sits at 36.7%, but overall factor performance suggests a need for improvement in asset and revenue utilization.

Fundamental(3.71)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.26
Score1/3
Weight10.63%
1M Return5.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight9.74%
1M Return5.89%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.31%
1M Return0.22%
Profit-MV
Value0.47
Score2/3
Weight14.88%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight15.08%
1M Return8.04%
PB-ROE
Value14.62
Score3/3
Weight22.38%
1M Return11.66%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.64%
1M Return1.75%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight2.25%
1M Return1.53%
Asset-MV
Value-0.51
Score0/3
Weight7.35%
1M Return4.17%
Cash-MV
Value-0.07
Score2/3
Weight14.74%
1M Return7.78%
Is EXOZ fundamentally strong?
  • EXOZ scores 3.71/10 on fundamentals and holds a Fair valuation at present. Backed by its -82.35% ROE, 0.00% net margin, -11.45 P/E ratio, 16.43 P/B ratio, and -25.61% earnings growth, these metrics solidify its Netural investment rating.